- Report
- April 2025
- 200 Pages
Global
From €4019EUR$4,490USD£3,424GBP
- Report
- May 2025
- 180 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- February 2025
- 181 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- January 2025
- 180 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP
- Report
- August 2024
- 240 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- May 2025
- 110 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- December 2024
- 200 Pages
Global
From €3357EUR$3,750USD£2,859GBP
- Report
- February 2025
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- December 2024
- 150 Pages
Global
From €2909EUR$3,250USD£2,478GBP
€4342EUR$4,850USD£3,698GBP
- Report
- January 2025
- 148 Pages
Global
From €2829EUR$3,160USD£2,410GBP
€3536EUR$3,950USD£3,012GBP
- Report
- January 2025
- 250 Pages
Global
From €4475EUR$4,999USD£3,812GBP
- Report
- March 2025
- 118 Pages
North America
From €3088EUR$3,450USD£2,631GBP
- Report
- October 2021
- 182 Pages
Global
From €4431EUR$4,950USD£3,774GBP
- Report
- July 2019
- 194 Pages
Global
From €2462EUR$2,750USD£2,097GBP
- Report
- March 2024
- 247 Pages
Global
From €3737EUR$4,175USD£3,183GBP
- Report
- February 2024
- 125 Pages
Global
From €5326EUR$5,950USD£4,537GBP
- Report
- February 2024
- 130 Pages
Global
From €5326EUR$5,950USD£4,537GBP
- Report
- March 2023
- 134 Pages
Global
From €5326EUR$5,950USD£4,537GBP
- Report
- October 2021
- 61 Pages
Global
From €4431EUR$4,950USD£3,774GBP
- Report
- May 2024
- 184 Pages
Global
From €3424EUR$3,825USD£2,917GBP
€4028EUR$4,500USD£3,431GBP

Alzheimer's Disease is a neurological disorder that affects memory, thinking, and behavior. It is the most common form of dementia, a group of disorders that cause a decline in cognitive function. Symptoms of Alzheimer's Disease include memory loss, difficulty with problem-solving, and changes in behavior. As the disease progresses, individuals may experience difficulty with language, disorientation, and difficulty with daily activities.
The Alzheimer's Disease market is a subset of the larger Neurology market. It is a rapidly growing market, driven by an aging population and increased awareness of the disease. Companies in the market are focused on developing treatments and therapies to improve the quality of life for those affected by the disease.
Companies in the Alzheimer's Disease market include Biogen, Eli Lilly, Novartis, and Roche. Other companies in the market include AbbVie, AstraZeneca, Merck, and Pfizer. Show Less Read more